YOLFTbeta
Nektar Therapeutics

Nektar Therapeutics

NKTR · NASDAQ · Healthcare / Biotechnology

37.27USD+0.02 (+0.05%)

Price History

Full chart

Market Stats

Previous Close37.25
Open36.80
Day Range36.28 – 38.70
52-Week Range33.40 – 109.00
Volume695.17K
Market Cap2.06B
P/E (TTM)0.00
Forward P/E34.01
EPS-6.12
Dividend Yield0.00%
Beta1.15
50-Day Avg70.72
200-Day Avg65.45

About

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Howard W. Robin
  • Employees63
  • Headquarters455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158, USA
  • Websitehttps://www.nektar.com

Leadership

  • Mr. Howard W. RobinCEO, President & Director · b. 1953
  • Dr. Jonathan Zalevsky Ph.D.Senior VP and Chief Research & Development Officer · b. 1975
  • Ms. Linda M. Rubinstein M.A.CFO and Principal Financial & Accounting Officer · b. 1967
  • Mr. Jason BarnardChief Accounting Officer
  • Ms. Elizabeth ZhangVP of Legal, Corporate Counsel & Secretary
  • Mr. Spilios AsimakopoulosVice President of Commercial Strategy & Marketing
  • Mr. Robert BacciChief People Officer and Head of Quality & Facilities
  • Ms. Jennifer RuddockChief Business Officer
  • Dr. Mary Tagliaferri L.Ac., M.D.Chief Medical Officer · b. 1966
  • Dr. Ken Franke Ph.D.Senior Vice President of Biologics Process Development & Manufacturing

Financials

Income Statement

Currency: USD1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.70M3.40M6.90M16.25M21.80M41.36M51.63M77.47M94.84M106.26M114.27M126.28M217.72M273.03M90.19M71.93M159.04M71.48M81.19M148.92M200.71M230.78M165.44M307.71M1.19B114.62M152.91M101.91M92.06M90.12M98.43M55.23M
Growth (%)-+100.00%+102.94%+135.49%+34.13%+89.76%+24.83%+50.05%+22.43%+12.03%+7.54%+10.51%+72.41%+25.40%-66.97%-20.24%+121.10%-55.06%+13.59%+83.42%+34.77%+14.99%-28.32%+86.00%+287.81%-90.40%+33.41%-33.36%-9.67%-2.10%+9.22%-43.89%
Cost of Revenue-500.00K-1.10M-1.20M---106.22M4.17M7.02M14.68M19.80M36.00M118.09M147.52M35.04M30.95M25.67M21.89M30.43M38.51M28.53M34.10M30.21M30.55M24.41M21.37M19.48M24.90M21.64M36.64M30.69M0
Gross Profit2.20M4.50M8.10M16.25M21.80M41.36M51.63M73.30M87.83M91.58M94.47M90.28M99.63M125.51M55.15M40.98M133.37M49.59M50.76M110.41M172.17M196.68M135.22M277.16M1.17B93.24M133.44M77.01M70.42M53.48M67.74M55.23M
Gross Margin129.41%132.35%117.39%100.00%100.00%100.00%100.00%94.62%92.60%86.19%82.67%71.49%45.76%45.97%61.15%56.98%83.86%69.37%62.52%74.14%85.78%85.22%81.74%90.07%97.95%81.35%87.26%75.57%76.50%59.34%68.82%100.00%
Operating Expense7.90M13.30M19.60M29.97M43.78M81.84M117.77M330.26M187.91M157.76M168.41M272.92M258.86M161.66M137.80M136.12M161.63M173.53M191.96M230.54M188.66M226.05M248.08M336.81M480.98M533.28M513.36M523.11M310.66M190.90M172.94M186.00M
Operating Income-5.70M-8.80M-11.50M-13.72M-21.99M-40.48M-66.14M-256.96M-100.08M-66.19M-73.94M-182.63M-159.23M-36.15M-82.65M-95.13M-28.25M-123.94M-141.20M-120.13M-16.48M-29.37M-112.86M-59.64M687.93M-440.04M-379.92M-446.10M-240.24M-137.43M-105.20M-130.77M
Operating Margin-335.29%-258.82%-166.67%-84.46%-100.89%-97.89%-128.10%-331.70%-105.52%-62.29%-64.71%-144.63%-73.14%-13.24%-91.65%-132.25%-17.77%-173.39%-173.91%-80.67%-8.21%-12.73%-68.22%-19.38%57.65%-383.92%-248.45%-437.76%-260.97%-152.49%-106.88%-236.77%
EBITDA-5.20M-7.70M-10.30M-11.29M-18.39M-23.34M-53.72M-70.32M-81.11M-47.77M-54.76M-147.07M-125.72M-7.12M2.54M-75.72M-9.33M-107.79M-124.10M-106.01M-2.74M-29.37M-97.27M-42.52M734.30M-382.70M-394.33M-461.82M-323.87M-243.11M-86.70M-137.00M
EBITDA Margin-305.88%-226.47%-149.28%-69.46%-84.39%-56.43%-104.06%-90.77%-85.52%-44.96%-47.92%-116.46%-57.74%-2.61%2.82%-105.26%-5.87%-150.79%-152.85%-71.18%-1.37%-12.73%-58.79%-13.82%61.53%-333.89%-257.87%-453.18%-351.82%-269.75%-88.08%-248.05%
Net Income-5.30M-7.70M-10.00M-9.98M-18.36M-38.45M-97.40M-250.01M-107.47M-46.68M-101.89M-185.11M-154.76M-32.76M-34.34M-102.52M-37.94M-133.98M-171.85M-162.01M-53.92M-81.18M-153.52M-96.69M681.31M-440.67M-444.44M-523.84M-368.20M-276.06M-118.96M-164.08M
Net Income Margin-311.76%-226.47%-144.93%-61.44%-84.22%-92.96%-188.66%-322.72%-113.31%-43.93%-89.16%-146.59%-71.08%-12.00%-38.07%-142.52%-23.85%-187.43%-211.67%-108.79%-26.86%-35.17%-92.80%-31.42%57.09%-384.47%-290.65%-514.03%-399.98%-306.31%-120.86%-297.07%
R&D-9.00M14.40M23.64M35.40M64.08M101.54M139.65M157.38M131.53M133.52M151.66M149.38M153.57M154.42M95.11M108.06M126.77M148.68M190.01M147.73M182.79M203.80M268.46M399.54M434.57M408.68M400.27M218.32M114.16M120.91M117.33M
R&D as % of Total Revenue-264.71%208.70%145.52%162.41%154.95%196.68%180.27%165.94%123.78%116.85%120.10%68.61%56.25%171.22%132.22%67.95%177.34%183.12%127.59%73.61%79.20%123.19%87.24%33.48%379.15%267.26%392.78%237.17%126.67%122.84%212.43%
Interest Expense00000012.14M13.43M16.61M17.90M25.75M14.09M20.26M18.64M15.19M12.18M11.17M10.22M33.55M40.76M38.76M38.90M42.18M40.95M42.78M46.35M37.12M47.31M28.91M25.33M28.11M26.18M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%23.51%17.34%17.52%16.84%22.53%11.15%9.30%6.83%16.85%16.93%7.03%14.30%41.32%27.37%19.31%16.86%25.50%13.31%3.58%40.44%24.27%46.43%31.41%28.11%28.56%47.41%

Balance Sheet

Currency: USD1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets17.20M23.20M41.50M119.76M134.50M226.81M629.54M667.24M606.64M616.79M744.92M858.55M768.18M725.10M560.54M575.52M521.23M606.55M497.79M434.53M441.62M502.06M568.87M508.87M2.15B1.98B1.54B1.12B710.60M398.03M303.85M280.41M
Total Liabilities1.80M3.00M6.40M22.67M18.61M140.18M351.66M396.93M399.87M452.60M277.58M531.74M541.12M510.66M370.38M473.15M430.56M408.74M450.77M524.43M405.29M495.63M480.75M421.04M432.60M571.97M461.47M437.68M343.96M267.05M243.11M190.57M
Total Equity15.40M20.20M35.10M97.09M115.88M86.63M277.88M270.31M206.77M164.19M467.34M326.81M227.06M214.44M190.15M102.37M90.66M197.81M47.02M-89.90M36.33M6.43M88.13M87.83M1.72B1.41B1.08B679.51M366.64M130.99M60.74M89.83M
Cash10.50M3.80M18.60M14.95M24.92M33.43M136.01M30.81M34.88M64.05M104.41M261.27M63.76M76.29M155.58M49.60M17.75M15.31M25.44M39.07M12.37M55.57M59.64M4.76M194.91M96.36M198.96M25.22M88.23M35.28M44.25M15.12M
Total Debt700.00K600.00K400.00K5.18M5.00M113.39M320.29M331.87M332.02M393.30M199.06M438.41M438.12M338.97M235.30M233.75M231.97M229.54M177.97M177.37M133.65M247.94M248.59M277.19M308.71M408.14M150.29M143.18M131.50M117.78M102.56M148.91M
Net Debt-9.80M-3.20M-18.20M-9.76M-19.91M79.96M184.27M301.05M297.14M329.25M94.65M177.14M374.36M262.67M79.72M184.16M214.21M214.22M111.17M93.98M121.29M192.37M188.96M240.44M52.05M311.77M-48.67M117.96M43.27M82.50M58.31M133.79M

Cash Flow

Currency: USD1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.00M-5.30M-5.80M4.98M-19.22M-15.33M-35.74M-50.77M-74.97M-76.20M-78.14M-78.00M-92.72M146.30M-145.78M39.74M-55.87M-113.74M-129.76M-38.53M-142.01M-73.08M-117.02M-80.41M718.21M-328.68M-313.29M-412.66M-304.01M-192.61M-175.71M-208.51M
Investing Cash Flow-1.50M-13.50M-3.80M-84.71M-6.50M-82.44M-299.75M-77.04M40.32M4.07M-88.91M32.40M-116.88M-32.66M274.65M-149.03M16.71M-111.95M113.02M49.91M-37.57M-14.34M-82.40M-28.81M-1.38B206.89M496.21M202.78M365.83M139.56M142.57M-1.20M
Financing Cash Flow14.30M12.20M24.40M76.11M36.53M106.29M438.07M22.61M38.72M101.30M207.41M274.85M11.77M-101.77M-49.74M3.54M7.54M222.34M26.80M2.22M152.98M130.78M203.62M54.39M851.97M23.36M-80.35M36.24M1.51M30.00K42.12M180.57M
Capital Expenditure1.40M1.30M2.20M17.26M34.58M20.50M53.85M34.32M16.33M18.75M27.19M17.95M22.52M32.80M18.86M20.70M31.46M9.72M10.58M4.09M9.98M11.20M6.39M9.68M14.24M26.29M7.26M14.99M5.68M865.00K1.47M171.00K
Free Cash Flow-5.40M-6.60M-8.00M-12.28M-53.81M-35.84M-89.59M-85.09M-91.30M-94.95M-105.34M-95.95M-115.24M113.51M-164.64M19.04M-87.33M-123.46M-140.34M-42.62M-151.98M-84.28M-123.42M-90.09M703.98M-354.97M-320.55M-427.65M-309.68M-193.47M-177.18M-208.68M
Dividends Paid----------6.69M1.28M-----0000000--------
FCF to OCF135.00%124.53%137.93%-246.68%279.91%233.70%250.66%167.60%121.78%124.60%134.80%123.02%124.29%77.58%112.93%47.91%156.30%108.55%108.16%110.62%107.03%115.32%105.46%112.03%98.02%108.00%102.32%103.63%101.87%100.45%100.84%100.08%
Dividend Paid to FCF-----------6.35%-1.33%-----0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateOct 23, 1995Jan 23, 1996Apr 17, 1996Jul 24, 1996Oct 22, 1996Jan 31, 1997Apr 24, 1997Jul 24, 1997Oct 6, 1997Jan 22, 1998Apr 21, 1998Jul 22, 1998Oct 22, 1998Jan 26, 1999Apr 21, 1999Jul 22, 1999Oct 25, 1999Jan 26, 2000Apr 19, 2000Jul 19, 2000Oct 23, 2000Jan 24, 2001May 1, 2001Aug 8, 2001Oct 24, 2001Jan 23, 2002May 2, 2002Jul 23, 2002Oct 22, 2002Jan 28, 2003Apr 22, 2003Aug 6, 2003Nov 5, 2003Feb 2, 2004May 5, 2004Aug 2, 2004Nov 3, 2004Mar 1, 2005May 9, 2005Aug 4, 2005Nov 3, 2005Feb 28, 2006May 10, 2006Aug 3, 2006Nov 2, 2006Feb 28, 2007May 9, 2007Aug 8, 2007Nov 7, 2007Feb 27, 2008May 7, 2008Aug 6, 2008Nov 6, 2008Feb 24, 2009May 6, 2009Aug 4, 2009Nov 4, 2009Mar 2, 2010May 5, 2010Jul 28, 2010Nov 4, 2010Mar 1, 2011Apr 27, 2011Aug 4, 2011Nov 2, 2011Feb 29, 2012May 2, 2012Aug 9, 2012Nov 9, 2012Feb 28, 2013May 9, 2013Aug 8, 2013Nov 7, 2013Feb 26, 2014May 7, 2014Jul 31, 2014Nov 6, 2014Feb 24, 2015Apr 30, 2015Aug 5, 2015Nov 5, 2015Mar 1, 2016May 3, 2016Aug 3, 2016Nov 4, 2016Mar 1, 2017May 9, 2017Aug 8, 2017Nov 7, 2017Mar 1, 2018May 10, 2018Aug 8, 2018Nov 7, 2018Feb 28, 2019May 8, 2019Aug 8, 2019Nov 6, 2019Feb 27, 2020May 7, 2020Aug 6, 2020Nov 5, 2020Feb 25, 2021May 6, 2021Aug 5, 2021Nov 4, 2021Feb 28, 2022May 5, 2022Aug 4, 2022Nov 3, 2022Feb 28, 2023May 9, 2023Aug 8, 2023Nov 7, 2023Mar 4, 2024May 9, 2024Aug 8, 2024Nov 7, 2024Mar 12, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Mar 13, 2026May 7, 2026Aug 13, 2026Nov 5, 2026
EPS Estimate-0.14-0.18-0.13-0.13-0.15-0.16-0.13-0.12-0.15-0.15-0.13-0.14-0.16-0.19-0.16-0.17-0.19-0.29-0.29-0.29-0.27-0.33-0.34-0.36-0.35-0.37-6.58-5.40-7.50-7.80-6.33-6.94-7.78-5.95-5.70-3.88-3.97-0.27-4.32-5.04-5.50-0.38-5.85-5.56-5.46-0.39-5.03-4.63-4.58-0.23-3.37-4.50-4.37-0.31-6.34-6.15-5.750.02-1.32-1.35-0.58-0.16-4.65-4.66-5.57-0.48-4.90-4.89-5.80-0.45-6.55-6.89-2.87-0.17-6.03-5.385.19-0.36-6.12-6.04-2.74-0.42-3.95-4.96-5.40-4.01-0.42-5.453.36-0.35-8.2079.30-9.46-0.65-11.34-12.00-10.83-10.30-0.77-10.32-11.28-0.68-10.90-10.98-12.09-0.81-10.01-15.25-6.54-0.45-3.59-3.30-2.40-0.21-3.07-3.01-3.09-0.13-2.82-3.13-2.79-3.50-1.48-2.06-2.20
EPS Actual-0.08-0.11-0.09-0.11-0.10-0.14-0.08-0.08-0.09-0.10-0.13-0.09-0.16-0.19-0.15-0.17-0.20-0.30-0.28-0.28-0.29-0.31-0.30-0.34-0.33-0.37-6.75-5.10-7.20-8.40-5.40-3.45-4.65-6.15-4.35-4.05-3.60-0.23-4.65-4.80-4.05-0.40-5.70-4.20-2.40-0.37-4.20-4.50-3.00-0.11-5.70-5.25-6.00-0.45-5.10-5.25-4.95-0.08-1.05-0.15-1.35-0.11-4.95-4.80-3.15-0.33-5.16-4.50-5.70-0.46-7.20-5.55-2.10-0.41-5.55-3.907.95-0.353.75-6.00-0.90-0.40-2.10-5.40-4.80-4.20-0.42-5.855.55-0.11-9.0079.95-8.40-0.57-10.20-9.45-8.40-9.60-0.53-6.75-9.15-0.65-10.20-10.35-10.50-0.79-7.35-12.75-4.65-0.32-3.75-4.05-2.85-0.22-2.76-2.81-2.65-0.15-3.61-2.95-1.87-1.29-1.78-1.23-
Surprise42.86%38.89%30.77%15.38%33.33%12.50%38.46%33.33%40.00%33.33%0.00%35.71%0.00%0.00%6.25%0.00%-5.26%-3.45%3.45%3.45%-7.41%6.06%11.76%5.56%5.71%0.00%-2.58%5.56%4.00%-7.69%14.69%50.29%40.23%-3.36%23.68%-4.38%9.32%14.81%-7.64%4.76%26.36%-5.26%2.56%24.46%56.04%5.13%16.50%2.81%34.50%52.17%-69.14%-16.67%-37.30%-45.16%19.56%14.63%13.91%-500.00%20.45%88.89%-132.76%31.25%-6.45%-3.00%43.45%31.25%-5.31%7.98%1.72%-2.22%-9.92%19.45%26.83%-141.18%7.96%27.51%53.18%2.78%161.27%0.66%67.15%4.76%46.84%-8.87%11.11%-4.74%0.00%-7.34%65.18%68.57%-9.76%0.82%11.21%12.31%10.05%21.25%22.44%6.80%31.17%34.59%18.88%4.41%6.42%5.74%13.15%2.47%26.57%16.39%28.90%28.89%-4.46%-22.73%-18.75%-4.76%10.10%6.64%14.24%-15.38%-28.01%5.75%32.97%63.10%-20.27%40.29%-
Timing------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap2.06B
Enterprise Value1.36B
Trailing P/E0.00
Forward P/E34.01
PEG Ratio0.31
Price / Sales37.78
Price / Book2.18
EPS-6.12
Book Value26.46
Revenue (TTM)54.59M
Gross Profit (TTM)54.59M
EBITDA-129.95M
Profit Margin-287.84%
Operating Margin-412.23%
Return on Equity-35.76%
Return on Assets-12.54%
Shares Outstanding34.14M
Shares Float28.53M
Beta1.15
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 8 analystsTarget 141.40
  • Strong Buy
    2
  • Buy
    2
  • Hold
    3
  • Sell
    1

Ownership Breakdown

Institutions
106.96%
Insiders
0.35%
Retail / Other
0.00%

Top Institutional Holders

  • FMR Inc
    4.30M12.60%
  • Bvf Inc
    2.56M7.50%
  • Two Seas Capital LP
    1.96M5.74%
  • Two Sigma Investments LLC
    1.20M3.52%
  • Vanguard Capital Management, LLC
    1.20M3.51%
  • Prosight Management, LP
    810.00K2.37%
  • BlackRock Inc
    692.65K2.03%
  • Morgan Stanley - Brokerage Accounts
    659.39K1.93%
  • Armistice Capital, LLC
    578.00K1.69%
  • Amvescap Plc.
    567.46K1.66%
  • Sofinnova Ventures
    509.55K1.49%
  • Millennium Management LLC
    478.12K1.40%
  • Woodline Partners LP
    415.33K1.22%
  • Lord, Abbett & Co LLC
    405.08K1.19%
  • Qube Research & Technologies
    390.68K1.14%

Top Fund Holders

  • Fidelity Growth Company Fund
    1.83M5.36%
  • Vanguard MStar Total Stk Mkt Idx Invest
    1.08M3.16%
  • iShares Russell 2000 ETF
    882.67K2.59%
  • Fidelity Growth Company K6
    495.04K1.45%
  • Fidelity Series Growth Company
    419.82K1.23%

Stock Splits

  • Jun 9, 20251:15
  • Aug 23, 20002:1